Reuters Health - A class of drugs called cholinesterase inhibitors, commonly used to treat people with Alzheimer’s disease, appear to increase the risk of fainting, Canadian and US researchers report.
Reuters Health - A class of drugs called cholinesterase inhibitors, commonly used to treat people with Alzheimer’s disease, appear to increase the risk of fainting, Canadian and US researchers report.
